Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study

References

• Papastergiou V, Georgopoulos SD, Karatapanis S. Treatment of Helicobacter pylori infection: past, present and future. World J Gastrointest Pathophysiol 2014;5:392–9.
   PubMedGoogle Scholar
• International Agency for Research on Cancer. Infection with Helicobacter pylori. In: IARC Working Group on the evaluation of carcinogenic risks to humans; Schistosomes, liver flukes and Helicobacter pylori: IARC Monographs on the evaluation of carcinogenic risks to humans, vol. 61. Lyon, France: International Agency for Research on Cancer; 1994:177–240.
   Google Scholar
• Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report. Gut 2012;61:646–64.
   PubMed Web of Science ®Google Scholar
• World Gastroenterology Organization. World Gastroenterology Organisation Global Guideline: Helicobacter pylori in developing countries. J Clin Gastroenterol 2011;45:383–8.
   PubMed Web of Science ®Google Scholar
• Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, et al. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection. J Gastroenterol Hepatol 2009;24:1587–600.
   PubMed Web of Science ®Google Scholar
• Chey WD, Wong BC. Practice Parameters Committee of the American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808–25.
   PubMed Web of Science ®Google Scholar
• Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 2014;20:5461–73.
   PubMed Web of Science ®Google Scholar
• De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 2010;19:409–14.
   PubMed Web of Science ®Google Scholar
• Papastergiou V, Georgopoulos SD, Karatapanis S. Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance. World J Gastroenterol 2014;20:9898–911.
   PubMed Web of Science ®Google Scholar
• Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010;59:1143–53.
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Bazzoli F, Delchier JC, Celiñski K, Giguère M, Rivière M, et al. Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial. Lancet 2011;377:905–13.
   PubMed Web of Science ®Google Scholar
• Graham DY, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy. Helicobacter 2007;12:275–8.
   PubMed Web of Science ®Google Scholar
• Papastergiou V, Georgopoulos SD, Karatapanis S. Current and future insights in H. pylori eradication regimens: the need of tailoring therapy. Curr Pharm Des 2014;20:4521–32.
   PubMed Web of Science ®Google Scholar
• Georgopoulos SD, Papastergiou V, Karatapanis S. Helicobacter  pylori eradication therapies in the era of increasing antibiotic resistance: a paradigm shift to improved efficacy. Gastroenterol Res Pract 2012;2012:757926.
   PubMed Web of Science ®Google Scholar
• Karamanolis GP, Daikos GL, Xouris D, Goukos D, Delladetsima I, Ladas SD. The evolution of Helicobacter pylori antibiotics resistance over 10 years in Greece. Digestion 2014;90:229–31.
   PubMed Web of Science ®Google Scholar
• Georgopoulos SD, Ladas SD, Karatapanis S, Triantafyllou K, Spiliadi C, Mentis A, et al. Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies. Aliment Pharmacol Ther 2002;16:569–75.
   PubMed Web of Science ®Google Scholar
• Georgopoulos SD, Xirouchakis E, Martinez-Gonzalez B, Sgouras DN, Spiliadi C, Mentis AF, et al. Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area. Helicobacter 2013;18:459–67.
   PubMed Web of Science ®Google Scholar
• Zullo A, Vaira D, Vakil N, Hassan C, Gatta L, Ricci C, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 2003;17:719–26.
   PubMed Web of Science ®Google Scholar
• Okada M, Nishimura H, Kawashima M, Okabe N, Maeda K, Seo M, et al. A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome. Aliment Pharmacol Ther 1999;13:769–74.
   PubMed Web of Science ®Google Scholar
• Wu DC, Hsu PI, Wu JY, Opekun AR, Kuo CH, Wu IC, et al. Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection. Clin Gastroenterol Hepatol 2010;8:36–41.
   PubMed Web of Science ®Google Scholar
• Huang YK, Wu MC, Wang SS, Kuo CH, Lee YC, Chang LL, et al. Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication. J Dig Dis 2012;13:232–8.
   PubMed Web of Science ®Google Scholar
• Lim JH, Lee DH, Choi C, Lee ST, Kim N, Jeong SH, et al. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study. Helicobacter 2013;18:180–6.
   PubMed Web of Science ®Google Scholar
• Hsu PI, Wu DC, Chen WC, Tseng HH, Yu HC, Wang HM, et al. Randomized controlled trial comparing 7-day triple, 10-day sequential, and 7-day concomitant therapies for Helicobacter pylori infection. Antimicrob Agents Chemother 2014;58:5936–42.
   PubMed Web of Science ®Google Scholar
• Greenberg ER, Anderson GL, Morgan DR, Torres J, Chey WD, Bravo LE, et al. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomized trial. Lancet 2011;378:507–14.
   PubMed Web of Science ®Google Scholar
• De Francesco V, Hassan C, Ridola L, Giorgio F, Ierardi E, Zullo A. Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study. J Med Microbiol 2014;63:748–52.
   PubMed Web of Science ®Google Scholar
• McNicholl AG, Marin AC, Molina-Infante J, Castro M, Barrio J, Ducons J, et al. Randomized clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice. Gut 2014;63:244–9.
   PubMed Web of Science ®Google Scholar
• Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 2013;62:34–42.
   PubMed Web of Science ®Google Scholar
• Boyanova L, Mentis A, Gubina M, Rozynek E, Gosciniak G, Kalenic S, et al. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect 2002;8:388–96.
   PubMed Web of Science ®Google Scholar
• Georgopoulos S, Papastergiou V, Xirouchakis E, Laoudi F, Lisgos P, Spiliadi C, et al. Nonbismuth quadruple “concomitant” therapy versus standard triple therapy, both of the duration of 10 days, for first-line H. pylori eradication: a randomized trial. J Clin Gastroenterol 2013;47:228–32.
   PubMed Web of Science ®Google Scholar
• Gatta L, Vakil N, Vaira D, Scarpignato C. Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ 2013;347:f4587.
   PubMed Web of Science ®Google Scholar
• dos Santos AA, Carvalho AA. Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review. World J Gastroenterol 2015;21:139–54.
   PubMed Web of Science ®Google Scholar
• Wu DC, Hsu PI, Wu JY, Opekun AR, Kuo CH, Wu IC, et al. Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection. Clin Gastroenterol Hepatol 2010;8:36–41.
   PubMed Web of Science ®Google Scholar
• He L, Deng T, Luo H. Meta-analysis of sequential, concomitant and hybrid therapy for Helicobacter pylori eradication. Intern Med 2015;54:703–10.
   PubMed Web of Science ®Google Scholar
• Kim JS, Park SM, Kim BW. Sequential or concomitant therapy for eradication of H. pylori infection: a systematic review and meta-analysis. J Gastroenterol Hepatol 2015;30:1338–45.
   PubMed Web of Science ®Google Scholar
• Georgopoulos S, Papastergiou V, Xirouchakis E, Laudi F, Papantoniou N, Lisgos P, et al. Evaluation of a four-drug, three-antibiotic, nonbismuth-containing “concomitant” therapy as first-line Helicobacter pylori eradication regimen in Greece. Helicobacter 2012;17:49–53.
   PubMed Web of Science ®Google Scholar
• Lim JH, Lee DH, Choi C, Lee ST, Kim N, Jeong SH, et al. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study. Helicobacter 2013;18:180–6.
   PubMed Web of Science ®Google Scholar
• Graham DY, Lee YC, Wu MS. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol 2014;12:177–86.
   PubMed Web of Science ®Google Scholar